Imadazole being fused to a 5- or 6-membered ring containing 0-2 further heteroatoms selected from N,O or S.
PK140890AUndetermined Publication Date: 2010-09-20BAYER SCHERING PHARMA AG
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200800991
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-09-20
Abstract
Compound of formula (1) wherein ring B and the pyrimidine to which it is fused, R4, R5, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitor of the Pi3K / Akt pathway.
Need to check novelty before this filing date? Find Prior Art